ReportWire

Tag: ISRG

  • U.S. stocks little changed in cautious trading ahead of inflation report, bank earnings

    U.S. stocks little changed in cautious trading ahead of inflation report, bank earnings

    [ad_1]

    U.S. stock indexes were edging higher on Wednesday with technology stocks looking to extend gains ahead of the December inflation report, which is expected to shed more direct light on when the Federal Reserve could dial back its two-year-long effort to tighten monetary policy and cool the economy.

    How are stock indexes trading

    • The S&P 500
      SPX
      rose 8 points, or 0.2%, to 4,764

    • The Dow Jones Industrial Average
      DJIA
      was up 38 points, or 0.1%, to 37,562

    • The Nasdaq Composite
      COMP
      gained 43 points, or 0.3%, to 14,901.

    On Tuesday, the Dow industrials fell 0.4%, to 37,525, while the S&P 500 declined 0.2%, to 4,757, and the Nasdaq Composite gained less than 0.1%, to 14,858.

    What’s driving markets

    Inflation and its impact on bond markets and the Federal Reserve’s monetary-policy trajectory are the primary focus for markets this week as investors remain on hold ahead of Thursday’s December inflation reading and high-profile corporate earnings reports on Friday, when some of the big banks will kick off the fourth-quarter 2023 earnings season.

    The S&P 500 sits less than 0.7% shy of its record high of 4796.6 touched a little over two years ago, after rallying strongly in the last few months primarily on hopes that easing inflation will allow the Fed to lower interest rates sooner and faster than the markets previously anticipated.

    The yield on the 10-year Treasury
    BX:TMUBMUSD10Y,
    the benchmark for borrowing costs, has fallen from 5% in October to 4.014% on Wednesday.

    But for this bullish narrative to play out, inflation must be seen continuing to fall back to the central bank’s 2% target. That’s why great importance is therefore being placed on the consumer-price index for December, which will be published at 8:30 a.m. Eastern on Thursday.

    See: These traders bet on surprise blip higher in key December inflation reading

    Economists forecast that annual headline CPI inflation inched up to 3.2% last month from 3.1% in November. The core reading, which strips out more volatile items like food and energy, is expected to fall from 4% to 3.8%.

    Adam Phillips, director of portfolio strategy at EP Wealth Advisors, said the CPI report may give investors enough confidence that the disinflation is likely to continue, even if the price levels are “still a very long way from anything that is considered healthy.”

    However, he cautioned that the economy has “certain factors” that are beyond the Fed’s control, such as the volatility in supply chains and growing geopolitical risks, as well as a potential resurgence in inflation, he told MarketWatch via phone on Wednesday.

    “[E]quities have remained broadly range-bound since just before Christmas, with little to push them in either direction,” said Jim Reid, strategist at Deutsche Bank.

    “That might change soon, since we’ve got the U.S. CPI print tomorrow, and then the start of earnings season on Friday, but for now at least, there’s been few headlines for investors to latch onto, just a bit of indigestion after over exuberance before New Year left markets with a little bit of an extended hangover,” Reid added.

    In U.S. economic data, the wholesale inventories declined 0.2% in November, in line with Wall Street expectations, as manufacturers continue to juggle with a fragile economy, according to the Commerce Department.

    New York Fed President John Williams will speak in White Plains, N.Y., at 3:15 p.m. Eastern time.

    Companies in focus

    [ad_2]

    Source link

  • ISRG Stock Price | Intuitive Surgical Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

    ISRG Stock Price | Intuitive Surgical Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

    [ad_1]

    Intuitive Surgical Inc.

    Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

    [ad_2]

    Steve Gelsi

    Source link

  • These 20 growth stocks are worth considering on a pullback, says Citi

    These 20 growth stocks are worth considering on a pullback, says Citi

    [ad_1]

    Citi has released a list of 20 large-cap growth stocks that it says present opportunities in the event of a pullback.

    “Our call since early summer has been to hold Growth and look to buy on pullbacks,” Citi analyst Scott Chronert said in a note released Monday, adding that Citi has had a tactical preference for cyclicals. “However, on the heels of the strong Cyclicals surge during June and July, and our upwardly revised S&P 500 target of 4600, the messaging has been to buy on pullbacks more broadly,” he wrote.

    Citi also notes that the Russell 1000 Growth Index
    RLG
    has sold off more than 6% from its mid-July high, although two-thirds of the stocks in the index are down 10% or more, with one-third down more than 20%. “This sets up for interesting intermediate to long-term stock selection opportunities,” Chronert said.

    Related: Preorders for the iPhone 15 have begun, and here’s a sign they’ve been ‘solid’

    The analyst acknowledged that there is still a risk of economic softening ahead, if not a recession. “Yet, the argument that Growth stocks can show fundamental resilience during periods of broader economic weakening is a theme that we have considered for several years now,” he said.

    Set against this backdrop, the analyst firm has compiled a tech-heavy list of 20 stocks that have a buy rating from Citi, have at least 75% of market cap assigned to growth, according to Russell, and have experienced a decline of 10% or more from year-to-date highs since March 31. Other common characteristics of the stocks include consensus estimates of free cash flow per share above March 31 levels and free cash flow per share within or above market-implied five-year-forward estimates.

    Tech heavyweights Apple Inc.
    AAPL,
    +0.74%

    and NVIDIA Corp.
    NVDA,
    +1.47%

    are on the list, along with Pinterest Inc.
    PINS,
    -2.47%
    ,
    Lam Research Corp.
    LRCX,
    +0.24%
    ,
    Teradata Corp.
    TDC,
    +0.36%
    ,
    Datadog Inc.
    DDOG,
    +0.09%
    ,
    MongoDB Inc.
    MDB,
    -0.73%
    ,
    HubSpot Inc.
    HUBS,
    +0.18%

    and KLA Corp.
    KLAC,
    +0.79%
    .
    The other stocks cited by Citi are Lockheed Martin Corp.
    LMT,
    -0.18%
    ,
    DraftKings Inc.
    DKNG,
    -1.44%
    ,
    Las Vegas Sands Corp.
    LVS,
    -0.98%
    ,
    Chipotle Mexican Grill Inc.
    CMG,
    -0.85%
    ,
    Netflix Inc.
    NFLX,
    +1.31%
    ,
    TKO Group Holdings Inc.
    TKO,
    -1.93%
    ,
    Rockwell Automation Inc.
    ROK,
    +1.09%

    and Paycom Software Inc.
    PAYC,
    +0.45%
    ,
    and healthcare stocks Bruker Corp.
    BRKR,
    +1.04%
    ,
    Insulet Corp.
    PODD,
    -0.66%

    and Intuitive Surgical Inc.
    ISRG,
    +1.75%
    .

    Related: Will Nvidia stock be like Apple or Cisco in the AI era?

    Shares of Apple, which recently launched its iPhone 15, are down 5.5% in the last three months. Shares of chip maker NVIDIA are up 2.8% over the same period, while Lockheed Martin is down 8.9% and DraftKings is up 8.6%. Las Vegas Sands is down 21.8% and Chipotle is down 8.8%, while Netflix is down 7.8%.

    [ad_2]

    Source link

  • Cwm LLC Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

    Cwm LLC Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

    [ad_1]

    Cwm LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 23.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,012 shares of the medical equipment provider’s stock after purchasing an additional 2,298 shares during the quarter. Cwm LLC’s holdings in Intuitive Surgical were worth $3,069,000 as of its most recent SEC filing.

    A number of other hedge funds have also recently made changes to their positions in the stock. Azimuth Capital Investment Management LLC increased its position in Intuitive Surgical by 48.4% during the 4th quarter. Azimuth Capital Investment Management LLC now owns 54,074 shares of the medical equipment provider’s stock valued at $14,349,000 after buying an additional 17,633 shares in the last quarter. Ferguson Wellman Capital Management Inc. acquired a new position in Intuitive Surgical during the 4th quarter valued at about $259,000. Mn Services Vermogensbeheer B.V. increased its position in Intuitive Surgical by 3.7% during the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 178,500 shares of the medical equipment provider’s stock valued at $45,601,000 after buying an additional 6,400 shares in the last quarter. Concord Wealth Partners increased its holdings in shares of Intuitive Surgical by 32.2% in the first quarter. Concord Wealth Partners now owns 530 shares of the medical equipment provider’s stock valued at $135,000 after purchasing an additional 129 shares during the period. Finally, First National Bank of Omaha acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $205,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

    Wall Street Analysts Forecast Growth

    A number of brokerages have issued reports on ISRG. Morgan Stanley increased their price target on Intuitive Surgical from $265.00 to $285.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 19th. Royal Bank of Canada raised their target price on Intuitive Surgical from $309.00 to $355.00 in a research report on Wednesday, July 12th. Evercore ISI raised their target price on Intuitive Surgical from $240.00 to $270.00 and gave the company an “inline” rating in a research report on Wednesday, April 19th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $250.00 to $335.00 and gave the company an “overweight” rating in a report on Wednesday, April 19th. Finally, Sanford C. Bernstein raised their target price on Intuitive Surgical from $350.00 to $365.00 in a research note on Wednesday, May 31st. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $323.48.

    Intuitive Surgical Price Performance

    Shares of NASDAQ ISRG opened at $347.66 on Friday. The company has a market capitalization of $121.82 billion, a price-to-earnings ratio of 94.99, a price-to-earnings-growth ratio of 6.33 and a beta of 1.32. Intuitive Surgical, Inc. has a 1 year low of $180.07 and a 1 year high of $358.07. The business has a 50-day moving average of $324.13 and a two-hundred day moving average of $281.19.

    Intuitive Surgical (NASDAQ:ISRGGet Free Report) last issued its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.09. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. Intuitive Surgical had a return on equity of 11.39% and a net margin of 20.40%. The firm’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.85 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 4.31 earnings per share for the current year.

    Insiders Place Their Bets

    In other Intuitive Surgical news, VP Marshall Mohr sold 11,250 shares of the business’s stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $325.00, for a total transaction of $3,656,250.00. Following the transaction, the vice president now owns 24,136 shares in the company, valued at approximately $7,844,200. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP David J. Rosa sold 40,764 shares of the company’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $299.20, for a total value of $12,196,588.80. Following the sale, the executive vice president now owns 155,712 shares in the company, valued at approximately $46,589,030.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Marshall Mohr sold 11,250 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $325.00, for a total value of $3,656,250.00. Following the completion of the sale, the vice president now owns 24,136 shares in the company, valued at approximately $7,844,200. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 63,347 shares of company stock worth $19,349,510. Company insiders own 0.90% of the company’s stock.

    Intuitive Surgical Profile

    (Free Report)

    Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

    See Also

    Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

    Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

    Receive News & Ratings for Intuitive Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link

  • China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is past

    China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is past

    [ad_1]

    A few days into the first Lunar New Year holiday since the lifting of pandemic restrictions in China, Chinese consumers are eager to travel but are also wary as a major COVID wave sweeps the nation, MarketWatch’s Tanner Brown reported.

    The 15-day festival is considered the world’s largest annual migration, during which students and workers return to their hometowns in droves — that is, until COVID shut down travel in 2020.

    On…

    [ad_2]

    Source link

  • ISRG Stock Price | Intuitive Surgical Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

    ISRG Stock Price | Intuitive Surgical Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

    [ad_1]

    Intuitive Surgical Inc.

    Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

    [ad_2]

    Source link